Šw‰ÈЉî

Œ’N‰ÈŠw•”@—Õ°ŒŸ¸Šw‰È@‚S”N§

‹ÆÑЉî

Ž–¼ ¼ú±@–ΓW Š‘® —Õ°ŒŸ¸Šw‰È
E–¼ @@ –ðE @@
ŠwˆÊ ”ŽŽmiˆãŠwj
’S“–Žö‹Æ‰È–Ú
i—ߘa2”N“xj
”÷¶•¨ŠwAƒ`[ƒ€ˆã—ÊT˜_A—Õ°ŒŸ¸ŠwŠî‘bŽÀK
Œ¤‹†‹ÆÑ
ƒ’˜‘„
  1. Phage therapy: a practical approach@‹¤’˜@—ߘaŒ³”N12ŒŽ@Springer Nature
  2. Methods in Molecular Biology, vol 1898, Bacteriophages@‹¤’˜@•½¬31”N1ŒŽ@Humana Press
  3. Methods in molecular biology 1693@Bacteriophage therapy from lab to clinical practice.i•ªŽq¶•¨Šw‚É‚¨‚¯‚é•û–@@Œ¤‹†Žº‚©‚ç—Õ°Œ»ê‚ւ̃oƒNƒeƒŠƒIƒtƒ@[ƒW—Ö@j@‹¤’˜@•½¬30”N1ŒŽ@Humana Press
  4. H‚Æ”÷¶•¨‚ÌŽ–“T@‹¤’˜@•½¬29”N7ŒŽ@’©‘q‘“X

ƒŒ¤‹†˜_•¶„
  1. Therapeutic effects of intravitreously administered bacteriophage in a mouse model of endophthalmitis caused by vancomycin-sensitive or -resistant Enterococcus faecalis.@‹¤’˜@—ߘaŒ³”N10ŒŽCAntimicrob Agents Chemother. 63(11):e01088-19.
    ’˜ŽÒ–¼FKishimoto T, Ishida W, Fukuda K, Nakajima I, Suzuki T, Uchiyama J, Matsuzaki S, Todokoro D, Daibata M, Fukushima A
  2. Dark-field microscopic detection of bacteria using bacteriophage-immobilized SiO 2@AuNP core-shell nanoparticles@‹¤’˜@—ߘaŒ³”N10ŒŽCAnal Chem. 91(19):12352-12357.
    ’˜ŽÒ–¼FImai M, Mine K, Tomonari H, Uchiyama J , Matsuzaki S , Niko Y, Hadano S, Watanabe Sj
  3. Therapeutic potential of an endolysin derived from Kayvirus S25-3 for Staphylococcal impetigo.@‹¤’˜@—ߘaŒ³”N8ŒŽCViruses 11(9) pii: E769
    ’˜ŽÒ–¼FImanishi I, Uchiyama J, Tsukui T, Hisatsune J, Ide K, Matsuzaki S, Sugai M, Nishifuji K
  4. Potential application of bacteriophages in enrichment culture for improved prenatal Streptococcus agalactiae screening.@‹¤’˜@•½¬30”N10ŒŽ@Viruses. 10(10). pii: E552.
    ’˜ŽÒ–¼FUchiyama J, Matsui H, Murakami H, Kato SI, Watanabe N, Nasukawa T, Mizukami K, Ogata M, Sakaguchi M, Matsuzaki S, Hanaki H
  5. Recovery of mycobacteriophages from archival stocks stored for approximately 50 years in Japan.@‹¤’˜@•½¬30”N7ŒŽ Arch Virol.163(7):1915-1919
    ’˜ŽÒ–¼FUjihara T, Uchiyama J, Nasukawa T, Ando H, Murakami H, Ohara N, Ogawa M, Yamazaki T, Daibata M, Sakaguchi M, Matsuzaki S
  6. Piperacillin and ceftazidime produce the strongest synergistic phage-antibiotic effect in Pseudomonas aeruginosa.@‹¤’˜@•½¬30”N7ŒŽ@Arch Virol. 163(7):1941-1948.
    ’˜ŽÒ–¼FUchiyama J, Shigehisa R, Nasukawa T, Mizukami K, Takemura-Uchiyama I, Ujihara T, Murakami H, Ima@nishi I, Nishifuji K, Sakaguchi M, Matsuzaki S
  7. ƒoƒNƒeƒŠƒIƒtƒ@[ƒW‚ð—˜—p‚·‚鑽ܑϫ‹ÛŠ´õǧŒä–@@‹¤’˜@•½¬30”N6ŒŽ@“®•¨—pƒƒNƒ`ƒ“-ƒoƒCƒIˆã–ò•iŒ¤‹†‰ïƒjƒ…[ƒXƒŒƒ^[17†A11-16ƒy[ƒW
    ’˜ŽÒ–¼F¼ú±–ΓWA“àŽR~•½
  8. Genome sequences of 12 Mycobacteriophages recovered from archival stocks in Japan.@‹¤’˜@•½¬30”N6ŒŽ@Genome Announc. 6(25). e00472-18.
    ’˜ŽÒ–¼FUchiyama J, Mizukami K, Yahara K, Kato SI, Murakami H, Nasukawa T, Ohara N, Ogawa M, Yamazaki T, Matsuzaki S, Sakaguchi M
  9. Polymorphisms in the Helicobacter pylori NY43 strain and its prophage-cured derivatives.@‹¤’˜@•½¬30”N6ŒŽ@Microbiology@164(6):877-882.
    ’˜ŽÒ–¼FTakeuchi H, Kira M, Konishi S, Uchiyama J, Matsuzaki S, Matsumura Y
  10. Prevalence and genetic variability of human polyomaviruses 6 and 7 in healthy skin among asymptomatic individuals.@‹¤’˜@•½¬30”N2ŒŽ@J Infect Dis. 217(3):483-493.
    ’˜ŽÒ–¼FHashida Y, Higuchi T, Matsuzaki S, Nakajima K, Sano S, Daibata M
  11. Virus purification by CsCl density gradient using general centrifugation.@‹¤’˜@•½¬29”N11ŒŽ@Arch Virol. 162(11):3523-3528.
    ’˜ŽÒ–¼FNasukawa T, Uchiyama J, Taharaguchi S, Ota S, Ujihara T, Matsuzaki S, Murakami H, Mizukami K, Sakaguchi M
  12. Adsorption of Staphylococcus viruses S13' and S24-1 on Staphylococcus aureus strains with different glycosidic linkage patterns of wall teichoic acids.@‹¤’˜@•½¬29”N8ŒŽ@J Gen Virol. 98(8):2171-2180.
    ’˜ŽÒ–¼FUchiyama J, Taniguchi M, Kurokawa K, Takemura-Uchiyama I, Ujihara T, Shimakura H, Sakaguchi Y, Murakami H, Sakaguchi M, Matsuzaki S
  13. High load of Merkel cell polyomavirus DNA detected in the normal skin of Japanese patients with Merkel cell carcinoma.@‹¤’˜@•½¬28”N9ŒŽ@J Clin Virol. 82:101-107
    ’˜ŽÒ–¼FHashida Y, Nakajima K, Nakajima H, Shiga T, Tanaka M, Murakami M, Matsuzaki S, Naganuma S, Kuroda N, Seki Y, Katano H, Sano S, Daibata M
  14. Analyses of short-term antagonistic evolution of Pseudomonas aeruginosa strain PAO1 and phage KPP22 (Myoviridae Family, PB1-Like Virus Genus).@‹¤’˜@•½¬28”N8ŒŽ@Appl Environ Microbiol. 82(15):4482-4491.
    ’˜ŽÒ–¼FUchiyama J, Suzuki M, Nishifuji K, Kato S, Miyata R, Nasukawa T, Yamaguchi K, Takemura-Uchiyama I, Ujihara T, Shimakura H, Murakami H, Okamoto N, Sakaguchi Y, Shibayama K, Sakaguchi M, Matsuzaki S
  15. Screening of KHP30-like prophages among Japanese Helicobacter pylori strains, and genetic analysis of a defective KHP30-like prophage sequence integrated in the genome of the H. pylori strain NY40.@‹¤’˜@•½¬28”N8ŒŽ@FEMS Microbiol Lett. 363(16). fnw157.
    ’˜ŽÒ–¼FUchiyama J, Takemura-Uchiyama I, Kato S, Takeuchi H, Sakaguchi Y, Ujihara T, Daibata M, Shimakura H, Okamoto N, Sakaguchi M, Matsuzaki S
  16. Characterization of Pseudomonas aeruginosa phage KPP21 belonging to family Podoviridae genus N4-like viruses isolated in Japan.@‹¤’˜@•½¬28”N1ŒŽ@Microbiol Immunol@60(1):64-67.
    ’˜ŽÒ–¼FShigehisa R, Uchiyama J, Kato S, Takemura-Uchiyama I, Yamaguchi K, Miyata R, Ujihara T, Sakaguchi Y, Okamoto N, Shimakura H, Daibata M, Sakaguchi M, Matsuzaki S

ƒ‘àEˆË—ŠŒ´e‚È‚Ç„
  1. Helicobacter pylori ƒtƒ@[ƒW‚Æ‚»‚̃Qƒmƒ€@‹¤’˜@•½¬28”N10ŒŽ@Helicobacter Research@20i5j:470-474.
  2. ׋ۊ´õǂɑ΂·‚éƒtƒ@[ƒW—Ö@‚̉”\«@‹¤’˜@•½¬28”N7ŒŽ@BioScan for your Lab No.1 p.08, Beckman Coulter,
  3. ƒEƒCƒ[ƒ€@ƒoƒNƒeƒŠƒIƒtƒ@[ƒW—Ö@@‹¤’˜@•½¬27”N11ŒŽ@—Õ°‚Æ”÷¶•¨42(6)F697-701

ƒŠw‰ï”­•\Eu‰‰‚È‚Ç„
  1. Recovery of mycobacteriophages from archival stocks stored for approximately 50 years in Japan.@‹¤“¯@•½¬30”N8ŒŽ@‘æ7‰ñƒtƒ@[ƒWŒ¤‹†‰ïE2018 ”N“ú–{׋ۊw‰ïŠÖ“ŒŽx•”ƒCƒ“ƒ^[ƒ‰ƒ{ƒZƒ~ƒi[‡“¯‘å‰ï
  2. ƒNƒ‰ƒCƒI“dŽqŒ°”÷‹¾‚É‚æ‚鉩FƒuƒhƒE‹…‹Ûƒtƒ@[ƒWS13'‚̋ߌ´Žq•ª‰ð”\\‘¢‰ðÍ@‹¤“¯@•½¬30”N8ŒŽ@‘æ7‰ñƒtƒ@[ƒWŒ¤‹†‰ïE2018”N“ú–{׋ۊw‰ïŠÖ“ŒŽx•”ƒCƒ“ƒ^[ƒ‰ƒ{ƒZƒ~ƒi[‡“¯‘å‰ï
  3. ˆê”ʉ“SŠí‚ð—˜—p‚µ‚½‰–‰»ƒZƒVƒEƒ€–§“xŒù”z‰“S–@‚É‚æ‚éƒEƒCƒ‹ƒX¸»‚ÌŒŸ“¢@‹¤“¯@•½¬30”N8ŒŽ@‘æ7‰ñƒtƒ@[ƒWŒ¤‹†‰ïE2018”N“ú–{׋ۊw‰ïŠÖ“ŒŽx•”ƒCƒ“ƒ^[ƒ‰ƒ{ƒZƒ~ƒi[‡“¯‘å‰ï
  4. BŒQ˜A½‹…‹ÛŒŸ¸Œüã‚ð–ÚŽw‚µ‚½ƒoƒNƒeƒŠƒIƒtƒ@[ƒW‚Ì“ÁˆÙ“I—n‹ÛŠˆ«‚Ì—˜—p@‹¤“¯@•½¬30”N8ŒŽ@‘æ7‰ñƒtƒ@[ƒWŒ¤‹†‰ïE2018”N“ú–{׋ۊw‰ïŠÖ“ŒŽx•”ƒCƒ“ƒ^[ƒ‰ƒ{ƒZƒ~ƒi[‡“¯‘å‰ï
  5. Therapeutic effects of bacteriophage ƒÓ EF24C-P2 on Enterococcus faecalis endophthalmitis in mice.@‹¤“¯@•½¬30”N8ŒŽ@‘æ7‰ñƒtƒ@[ƒWŒ¤‹†‰ïE2018”N“ú–{׋ۊw‰ïŠÖ“ŒŽx•”ƒCƒ“ƒ^[ƒ‰ƒ{ƒZƒ~ƒi[‡“¯‘å‰ï
  6. ƒoƒNƒeƒŠƒIƒtƒ@[ƒWKHP30‚Éì—p‚·‚éHelicobacter pylori•Û—L‚̧ŒÀ|CüŒn‚̉ðÍ@‹¤“¯@•½¬30”N8ŒŽ@‘æ7‰ñƒtƒ@[ƒWŒ¤‹†‰ïE2018”N“ú–{׋ۊw‰ïŠÖ“ŒŽx•”ƒCƒ“ƒ^[ƒ‰ƒ{ƒZƒ~ƒi[‡“¯‘å‰ï
  7. ’°‹…‹ÛŠá“à‰Š‚ɑ΂·‚éƒoƒNƒeƒŠƒIƒtƒ@[ƒW—Ö@‚ÌŒø‰Ê@‹¤“¯@•½¬30”N7ŒŽ@2018ƒtƒH[ƒTƒ€“Œ‹ži‘æ55‰ñ ŠáŠ´õÇŠw‰ïj
  8. ƒtƒ@[ƒW‚ð—p‚¢‚½ƒsƒƒŠ‹Û‚É‚¨‚¯‚駌À\CüŒn‚̉ðÍ@‹¤“¯@•½¬30”N6ŒŽ@•½¬30”N“x’†Žl‘“ûŽ_‹ÛŒ¤‹†‰ï‘‰ï‚¨‚æ‚ÑŒ¤‹†”­•\‰ï
  9. –òÜ‘Ï«Ž•ž‚ÉŒü‚¯‚½ƒoƒNƒeƒŠƒIƒtƒ@[ƒW—Ö@‚ÉŠÖ‚·‚éŠî‘b“IŒ¤‹†@‹¤“¯@•½¬30”N5ŒŽ@‘æ72‰ñ“ú–{Œûo‰ÈŠw‰ïŠwpW‰ï
  10. ƒNƒ‰ƒCƒI“dŽqŒ°”÷‹¾‚É‚æ‚鉩FƒuƒhƒE‹…‹Ûƒtƒ@[ƒWS13f‚̋ߌ´Žq•ª‰ð”\’P—±Žq‰ðÍ@‹¤“¯@•½¬30”N5ŒŽ@‘æ74‰ñ“ú–{Œ°”÷‹¾Šw‰ï, ƒVƒ“ƒ|ƒWƒEƒ€ S-2@ƒNƒ‰ƒCƒI“dŽqŒ°”÷‹¾–@‚Æ\‘¢¶–½‰ÈŠw‚Ì«—ˆ‘œ
  11. Therapeutic effects of intravitreous bacteriophage on vancomycin-resistant Enterococcal endophthalmitis in mice.@‹¤“¯@•½¬30”N5ŒŽ@Targeting Phage & Antibiotic Resistance 2018.
  12. Therapeutic effects of bacteriophage ƒÓEF24C-P2 on Enterococcus faecalis endophthalmitis in mice.@‹¤“¯@•½¬30”N5ŒŽ@Targeting Phage & Antibiotic Resistance 2018.
  13. ”畆‚É‚¨‚¯‚郃‹ƒPƒ‹×–Eƒ|ƒŠƒI[ƒ}ƒEƒCƒ‹ƒX—Ê‚Æ”­‚ª‚ñ‚Æ‚ÌŠÖ˜A«‚ɂ‚¢‚Ä@‹¤“¯@•½¬30”N2ŒŽ@‘æ17‰ñKMS Research Meeting
  14. High load of MCPyV in the nonlesional skin of patients with Merkel cell carcinoma and among a cohort of asymptomatic elderly individuals.@‹¤“¯@•½¬29”N12ŒŽ@“ú–{Œ¤‹†”畆‰ÈŠw‰ï‘æ42‰ñ”NŽŸŠwp‘å‰ï
  15. –òÜ‘Ï«‹Û‚ɑ΂·‚éƒoƒNƒeƒŠƒIƒtƒ@[ƒW—Ö@‚Ì‘no@‹¤“¯@•½¬29”N11ŒŽ@‘æ65‰ñ“ú–{Œûo‰ÈŠw‰ï’†‘EŽl‘’n•û•”‰ï
  16. The relationship between loads of Merkel cell polyomavirus and carcinogenesis.@‹¤“¯@•½¬29”N10ŒŽ@‘æ65‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï
  17. The head structure of the Staphylococcus aureus phage S13f at near atomic resolution by cryo-electron microscopy single particle analysis.@‹¤“¯@•½¬29”N9ŒŽ@2017”N¶•¨•¨—Šw‰ï
  18. Biocontrol of bacterial infections using bacteriophages: bacteriophage therapy and bacterial detection using bacteriophage molecules.@‹¤“¯@•½¬29”N9ŒŽ@The 16th Awaji International Forum on Infection and Immunity.
  19. Study of adsorption of AHJD-like phages infecting Staphylococcus aureus.@‹¤“¯@•½¬29”N3ŒŽ@‘æ90‰ñ“ú–{׋ۊw‰ï‘‰ï
  20. ƒoƒNƒeƒŠƒIƒtƒ@[ƒWKHP30‚ÌŠ´õ”\‚É‹y‚Ú‚·ƒsƒƒŠ‹Û•Û—L§ŒÀ-CüŒn‚̉ðÍ@‹¤“¯@•½¬29”N3ŒŽ@‘æ90‰ñ“ú–{׋ۊw‰ï‘‰ï
  21. Œ’í”畆‚É‚¨‚¯‚éu‚ª‚ñƒEƒCƒ‹ƒXv‚̃GƒRƒƒW[@‹¤“¯@•½¬29”N2ŒŽ@‘æ16‰ñKMS Research Meeting
  22. Screening of KHP30-like prophage in Helicobacter pylori using Japanese strains, and analysis of their fate by in silico approach.@‹¤“¯@•½¬28”N10ŒŽ@ƒtƒ@[ƒWEŠÂ‹«ƒEƒCƒ‹ƒXŒ¤‹†‰ï‡“¯ƒVƒ“ƒ|ƒWƒEƒ€i‘æ6‰ñƒtƒ@[ƒWŒ¤‹†‰ïj
  23. V‹KPB1—lƒtƒ@[ƒWKPP22‚ƗΔ^‹ÛPAO1Š”‚ð—˜—p‚µ‚½‘O“K‰žƒtƒ@[ƒWKPP22M쬉ߒö‚̈â“`“I‰ðÍ@‹¤“¯@•½¬28”N10ŒŽ@ƒtƒ@[ƒWEŠÂ‹«ƒEƒCƒ‹ƒXŒ¤‹†‰ï‡“¯ƒVƒ“ƒ|ƒWƒEƒ€i‘æ6‰ñƒtƒ@[ƒWŒ¤‹†‰ïj
  24. Phylogenetic analysis of Merkel cell polyomavirus based on full-length LT and VP1 sequences derived from normal skin of healthy individuals.@‹¤“¯@•½¬28”N10ŒŽ@‘æ64‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï
  25. Epidemiological study of Merkel cell polyomavirus in healthy skin among healthy individuals in Japan.@‹¤“¯@•½¬28”N10ŒŽ@‘æ64‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï
  26. ƒsƒƒŠ‹ÛƒQƒmƒ€‚É—nŒ´‰»‚µ‚½KHP30—lƒtƒ@[ƒWDNA‚Ö‚Ì‘}“ü”z—ñ‚Ì“]ˆÚ@‹¤“¯@•½¬28”N10ŒŽ@‘æ69‰ñ“ú–{׋ۊw‰ï’†‘EŽl‘Žx•”‘‰ï
  27. ƒoƒNƒeƒŠƒIƒtƒ@[ƒW‚ð—˜—p‚·‚éƒsƒƒŠ‹Ûœ‹Û–@ŠJ”­‚Ì‚½‚ß‚ÌŠî‘b“IŒ¤‹†@‹¤“¯@•½¬28”N5ŒŽ@•½¬28”N“x’†Žl‘“ûŽ_‹ÛŒ¤‹†‰ï‘‰ï‚¨‚æ‚ÑŒ¤‹†”­•\‰ï
  28. CŒ^ƒ{ƒcƒŠƒkƒX“Å‘f•ÏŠ·ƒtƒ@[ƒW‚̃Qƒmƒ€”äŠr‚ƈâ“`Žq‰ðÍ@‹¤“¯@•½¬28”N3ŒŽ@‘æ89‰ñ“ú–{׋ۊw‰ï‘‰ï
  29. Mycobacterium smegmatis‚ÉŠ´õ‚·‚éƒoƒNƒeƒŠƒIƒtƒ@[ƒW‚ÌŒ`‘ÔŠw“I‰ðÍ@‹¤“¯@•½¬28”N3ŒŽ@‘æ89‰ñ“ú–{׋ۊw‰ï‘‰ï
  30. —Δ^‹ÛPAO1Š”‚ƃtƒ@[ƒWKPP22‚Ì’ZŠúŠÔi‰»“IŒRŠg‹£‘ˆ‚̉ðÍ@‹¤“¯@•½¬28”N3ŒŽ@‘æ89‰ñ“ú–{׋ۊw‰ï‘‰ï
  31. Šˆ«Œ^ƒsƒƒŠ‹Ûƒtƒ@[ƒWKHP30‚Ì“Á’¥•t‚¯‚Æ‚»‚Ìö•šŠ´õ«‚̉ðÍ@‹¤“¯@•½¬28”N3ŒŽ@‘æ89‰ñ“ú–{׋ۊw‰ï‘‰ï iƒ[ƒNƒVƒ‡ƒbƒv@ƒtƒ@[ƒWEƒ‹ƒlƒbƒTƒ“ƒX@|ƒtƒ@[ƒW”­Œ©‚©‚ç100”N‚½‚Á‚½¡\j
  32. ƒtƒ@[ƒWƒŒƒZƒvƒ^[•ªŽq‚Ì“Á’è‚Æ‹@”\‰ð–¾@’P“Æ@•½¬28”N2ŒŽ@‘æ22-27”N“x‚’m‘åŠwŒ¤‹†‹’“_ƒvƒƒWƒFƒNƒgw¶–½ƒVƒXƒeƒ€‚ð§Œä‚·‚鶑̖Œ‹’“_xÅIƒVƒ“ƒ|ƒWƒEƒ€
  33. Šà“]ˆÚ—}§•ªŽqNm23-H1‚Í×–E‘¤•W“I“I•ªŽqAsef2‹y‚ÑAsef1‚ð‰î‚µ‚Ä“]ˆÚ‚ð§Œä‚µ‚Ä‚¢‚é@‹¤“¯@•½¬27”N10ŒŽ@‘æ74‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï
  34. Mycobacterium smegmatis ƒoƒNƒeƒŠƒIƒtƒ@[ƒW‚Ì’·Šú•Û‘¶ó‘Ô‚É‚¨‚¯‚鶑¶—¦@‹¤“¯@•½¬27”N10ŒŽ@‘æ 68‰ñ“ú–{׋ۊw‰ï’†‘Žl‘Žx•”‘‰ï
  35. ƒsƒƒŠ‹Û‚É‚¨‚¯‚é“àÝ«ƒoƒNƒeƒŠƒIƒtƒ@[ƒW‚Ì•Û—L󋵂̌Ÿ“¢‚Æ‚»‚ê‚ç‚Ì•ª—ÞŠw“IE¶‘ÔŠw“I‰ðÍ@’P“Æ@•½¬27”N6ŒŽ@Œö‰và’c–@l”­yŒ¤‹†Š‘æ‚X‰ñ•¬Œ¤‹†•ñ‰ïuˆê”ÊŒ¤‹†•¬v
  36. —Δ^‹ÛŠ´õǂɑ΂·‚éƒtƒ@[ƒW—Ö@‚Ɖ»Šw—Ö@‚Ì•¹—p—Ö@‚̉”\«ŒŸ“¢@‹¤“¯@•½¬27”N3ŒŽ@‘æ88‰ñ“ú–{׋ۊw‰ï‘‰ï
  37. ŠeŽíƒtƒ@[ƒW‚ɑ΂·‚鉩FƒuƒhƒE‹…‹ÛŽó—e‘̂̉ðÍ@‹¤“¯@•½¬27”N3ŒŽ@‘æ88‰ñ“ú–{׋ۊw‰ï‘‰ï
  38. BŒ^ƒ{ƒcƒŠƒkƒX‹Û‚̃{ƒcƒŠƒkƒX“Å‘fˆâ“`Žq‚ðƒR[ƒh‚·‚éƒvƒ‰ƒXƒ~ƒh‰ðÍ@‹¤“¯@•½¬27”N3ŒŽ@‘æ88‰ñ“ú–{׋ۊw‰ï‘‰ï
  39. ƒsƒƒŠ‹ÛNY43Š”‚̃tƒ@[ƒW•Û—LƒƒJƒjƒYƒ€‚̉ðÍ@‹¤“¯@•½¬27”N2ŒŽ@‘æ14‰ñKochi Medical School (KMS) Research Meeting
  40. —Δ^‹ÛŠ´õǂɑ΂·‚éƒtƒ@[ƒW—Ö@‚Ɖ»Šw—Ö@‚Ì•¹—p—Ö@‚̉”\«ŒŸ“¢@‹¤“¯@•½¬27”N2ŒŽ@‘æ14‰ñKochi Medical School (KMS) Research Meeting
  41. ŠeŽíƒtƒ@[ƒW‚ɑ΂·‚鉩FƒuƒhƒE‹…‹ÛŽó—e‘̂̉ðÍ@‹¤“¯@•½¬27”N2ŒŽ@‘æ14‰ñKochi Medical School (KMS) Research Meeting